Dimensional Fund Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-79,755
| Closed | -$985K | – | 3380 |
|
|
2024
Q4 | $985K | Sell |
79,755
-239,013
| -75% | -$2.74M | ﹤0.01% | 2917 |
|
|
2024
Q3 | $3.63M | Sell |
318,768
-141,391
| -31% | -$1.42M | ﹤0.01% | 2619 |
|
|
2024
Q2 | $3.29M | Sell |
460,159
-91,873
| -17% | -$703K | ﹤0.01% | 2624 |
|
|
2024
Q1 | $3.7M | Sell |
552,032
-177,360
| -24% | -$1.22M | ﹤0.01% | 2621 |
|
|
2023
Q4 | $4.74M | Sell |
729,392
-285,931
| -28% | -$1.84M | ﹤0.01% | 2574 |
|
|
2023
Q3 | $9.59M | Sell |
1,015,323
-166,338
| -14% | -$2M | ﹤0.01% | 2280 |
|
|
2023
Q2 | $16.5M | Buy |
1,181,661
+102,416
| +9% | +$1.75M | 0.01% | 2029 |
|
|
2023
Q1 | $20.2M | Buy |
1,079,245
+110,602
| +11% | +$1.82M | 0.01% | 1905 |
|
|
2022
Q4 | $13.3K | Buy |
968,643
+186,657
| +24% | +$2.86M | ﹤0.01% | 2064 |
|
|
2022
Q3 | $15M | Buy |
781,986
+128,326
| +20% | +$2.34M | 0.01% | 1973 |
|
|
2022
Q2 | $9.97M | Sell |
653,660
-48,978
| -7% | -$724K | ﹤0.01% | 2196 |
|
|
2022
Q1 | $14.3M | Sell |
702,638
-62,838
| -8% | -$1.28M | ﹤0.01% | 2140 |
|
|
2021
Q4 | $22.3M | Sell |
765,476
-119,903
| -14% | -$3.43M | 0.01% | 1920 |
|
|
2021
Q3 | $19.1M | Buy |
885,379
+120,178
| +16% | +$2.9M | 0.01% | 2028 |
|
|
2021
Q2 | $19.6M | Buy |
765,201
+370,378
| +94% | +$7.91M | 0.01% | 2048 |
|
|
2021
Q1 | $7.21M | Buy |
394,823
+341,475
| +640% | +$5.67M | ﹤0.01% | 2445 |
|
|
2020
Q4 | $616K | Buy |
+53,348
| New | +$488K | ﹤0.01% | 3056 |
|
Other funds holding CDMO
Dimensional Fund Advisors's CDMO Position: Q1 2025 in Review
Dimensional Fund Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 79,755 shares — an estimated $985K sold.
Dimensional Fund Advisors first reported a position in CDMO in Q4 2020 and held it in 17 quarters. The position peaked at $22.3M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Dimensional Fund Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Dimensional Fund Advisors sold 79,755 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $985K.
- Dimensional Fund Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 17 quarters.
- Dimensional Fund Advisors's Avid Bioservices, Inc. Common Stock position peaked at $22.3M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.